141 related articles for article (PubMed ID: 36201369)
21. A Single-Center Retrospective Review of Patients with Suspected Malignant Hyperthermia Susceptibility.
Edwards C; Dooley FC; Gonzalez S; Austin TM; Gravenstein N
Cureus; 2023 Sep; 15(9):e44661. PubMed ID: 37799222
[TBL] [Abstract][Full Text] [Related]
22. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
[TBL] [Abstract][Full Text] [Related]
23. Multigenerational Brazilian family with malignant hyperthermia and a novel mutation in the RYR1 gene.
Matos AR; Sambuughin N; Rumjanek FD; Amoedo ND; Cunha LB; Zapata-Sudo G; Sudo RT
Braz J Med Biol Res; 2009 Dec; 42(12):1218-24. PubMed ID: 19918671
[TBL] [Abstract][Full Text] [Related]
24. Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations.
Fiege M; Wappler F; Weisshorn R; Ulrich Gerbershagen M; Steinfath M; Schulte Am Esch J
Anesthesiology; 2002 Aug; 97(2):345-50. PubMed ID: 12151923
[TBL] [Abstract][Full Text] [Related]
25. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.
Nelson TE; Flewellen EH
Anesthesiology; 1979 Feb; 50(2):118-22. PubMed ID: 434484
[TBL] [Abstract][Full Text] [Related]
26. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
[TBL] [Abstract][Full Text] [Related]
27. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
Sudo RT; Cunha LB; Carmo PL; Matos AR; Trachez MM; Cardoso LA; Aguiar MI; Abreu AV; Zapata-Sudo G
Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345
[TBL] [Abstract][Full Text] [Related]
28. Rhabdomyolysis after infection and taking a cold medicine in a patient who was susceptible to malignant hyperthermia.
Kasamatsu Y; Osada M; Ashida K; Azukari K; Yoshioka K; Ohsawa A
Intern Med; 1998 Feb; 37(2):169-73. PubMed ID: 9550599
[TBL] [Abstract][Full Text] [Related]
29. Malignant hyperthermia.
Ben Abraham R; Adnet P; Glauber V; Perel A
Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
[TBL] [Abstract][Full Text] [Related]
30. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantrolene.
Wappler F; Scholz J; von Richthofen V; Fiege M; Köchling A; Lambrecht W; Schulte am Esch J
Acta Anaesthesiol Scand; 1997 Nov; 41(10):1312-8. PubMed ID: 9422298
[TBL] [Abstract][Full Text] [Related]
32. RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor Dysfunction.
Kruijt N; den Bersselaar LV; Snoeck M; Kramers K; Riazi S; Bongers C; Treves S; Jungbluth H; Voermans N
Curr Pharm Des; 2022; 28(1):2-14. PubMed ID: 34348614
[TBL] [Abstract][Full Text] [Related]
33. The effect of azumolene on hypercontractility and sarcoplasmic reticulum Ca(2+)-dependent ATPase activity of malignant hyperpyrexia-susceptible porcine skeletal muscle.
Foster PS; Hopkinson KC; Payne N; Denborough MA
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):489-95. PubMed ID: 1833102
[TBL] [Abstract][Full Text] [Related]
34. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.
Allen GC; Larach MG; Kunselman AR
Anesthesiology; 1998 Mar; 88(3):579-88. PubMed ID: 9523799
[TBL] [Abstract][Full Text] [Related]
35. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.
Allen GC; Rosenberg H; Fletcher JE
Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777
[TBL] [Abstract][Full Text] [Related]
36. The effects of dantrolene in the presence or absence of ryanodine receptor type 1 variants in individuals predisposed to malignant hyperthermia.
Noda Y; Mukaida K; Miyoshi H; Nakamura R; Yasuda T; Saeki N; Nishino I; Tsutsumi YM
Anaesth Intensive Care; 2022 Jul; 50(4):312-319. PubMed ID: 35549722
[TBL] [Abstract][Full Text] [Related]
37. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy").
Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Menge M; Schulte Am Esch J
Anesthesiology; 2003 Nov; 99(5):1132-6. PubMed ID: 14576550
[TBL] [Abstract][Full Text] [Related]
38. Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.
Klingler W; Heiderich S; Girard T; Gravino E; Heffron JJ; Johannsen S; Jurkat-Rott K; Rüffert H; Schuster F; Snoeck M; Sorrentino V; Tegazzin V; Lehmann-Horn F
Orphanet J Rare Dis; 2014 Jan; 9():8. PubMed ID: 24433488
[TBL] [Abstract][Full Text] [Related]
39. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
Tong J; Oyamada H; Demaurex N; Grinstein S; McCarthy TV; MacLennan DH
J Biol Chem; 1997 Oct; 272(42):26332-9. PubMed ID: 9334205
[TBL] [Abstract][Full Text] [Related]
40. Malignant hyperthermia.
Halliday NJ
J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
